Skip to main content
SpringerLink
Log in
Book cover

Diabetes-Therapie – informiert entscheiden pp 123–125Cite as

Fall 32: Spätschäden – 48 Jahre, ♀, DM Typ 1, Insulinresistenz, Anstieg des Body-Mass-Index

  • Chapter
  • First Online:

  • 2277 Accesses

Zusammenfassung

Eine 48-jährige Typ-1-Diabetikerin mit einem um 8 % eingestelltem HbA1c-Wert, einem LDL von 135 mg/dl hat jetzt seit Entwicklung einer Albuminurie eine Insulinresistenz bei einem Anstieg des Body-Mass-Index von ursprünglich 23 auf 33. Hat sie jetzt Typ-2-Diabetes und ändert dies etwas an ihrer Therapie?

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Cleland SJ et al (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia 56(7):1462–1470

    Article  CAS  Google Scholar 

  • Erbey JR et al (1998) The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 21(4):610–614

    Article  CAS  Google Scholar 

  • Ku E et al (2016) Association between blood pressure and adverse renal events in type 1 diabetes. Diabetes Care 39(12):2218–2224

    Article  CAS  Google Scholar 

  • Lewis EJ et al (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. the collaborative study group. N Engl J Med 329(20):1456–1462

    Article  CAS  Google Scholar 

  • Purnell JQ et al (1998) Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 280(2):140–146

    CAS  PubMed  Google Scholar 

  • Purnell JQ et al (2003) Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 52(10):2623–2629

    Article  CAS  Google Scholar 

  • Ray KK et al (2017) Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 170(12):1024–1031

    Article  Google Scholar 

  • Roglic G et al (1998) Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 15(5):418–426

    Article  CAS  Google Scholar 

  • Thorn LM et al (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32(5):950–952

    Article  Google Scholar 

  • Yip J et al (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342(8876):883–887

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Deutschland

    Stefan Kopf

Authors
  1. Stefan Kopf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Kopf .

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Lars Kihm

  2. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Stefan Kopf

  3. Zentrum für Innere Medizin I und klinische Chemie, Medizinische Universitätsklinik, Heidelberg, Germany

    Peter Nawroth

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kopf, S. (2018). Fall 32: Spätschäden – 48 Jahre, ♀, DM Typ 1, Insulinresistenz, Anstieg des Body-Mass-Index. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55972-7_32

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55971-0

  • Online ISBN: 978-3-662-55972-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation